Renal Cancer - Results from #4260

Advances in the Treatment of Metastatic Renal Cell Carcinoma September 12, 2018

Avelumab Plus Axitinib Significantly Improved Progression-Free Survival In Previously Untreated Patients with Advanced Renal Cell Carcinoma in Phase III Study September 12, 2018

Cardiotoxicities associated with immune checkpoint inhibitors September 11, 2018

Ten-year outcomes of renal tumor radiofrequency ablation September 11, 2018

Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma September 10, 2018

Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma September 10, 2018

Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma September 10, 2018

New Recommendations for CABOMETYX® (Cabozantinib) Tablets in Updated National Comprehensive Cancer Network Clinical Practice Guidelines September 7, 2018

Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis September 6, 2018

Ipilimumab in combination with nivolumab for the treatment of renal cell carcinoma September 5, 2018

Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma September 5, 2018

Perioperative and local control outcomes of robot-assisted partial nephrectomy vs percutaneous cryoablation for renal masses: Comparison after matching on radiological stage and renal score September 5, 2018

Adjuvant treatment in renal cell carcinoma September 5, 2018

Not Your Usual Suspect: Clear Cell Renal Cell Carcinoma Presenting as Ulcerative Esophagitis September 4, 2018

Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry September 4, 2018

The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era September 4, 2018

Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study. September 3, 2018

Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development September 3, 2018

[Comparison of safety and effectiveness between retroperitoneal laparoscopic tumor aspiration and laparoscopic partial nephrectomy in the treatment of renal angiomyolipoma] September 3, 2018

Bosniak category III renal cysts caused by crizotinib in an anaplastic lymphoma kinase gene-rearranged non-small cell lung cancer patient August 31, 2018

Page 214 of 457